Key result
Percutaneous mitral valve repair using the MitraClip system achieved 100% acute procedural success and 0% major adverse events at 30 days in 5 patients with severe mitral regurgitation.
Why the study?
Is percutaneous mitral repair with the MitraClip system safe and effective in patients with severe mitral regurgitation?
Observational (n=5)
Is percutaneous mitral repair with the MitraClip system safe and effective in patients with severe mitral regurgitation?
Initial experience in Egypt demonstrates that percutaneous mitral valve repair with the MitraClip system is feasible and safe in a small cohort of patients with severe MR.
No takes yet. Share an insight, caveat, or question.
Supports feasibility in small Egyptian cohort; leaves open need for larger trials before wider adoption.
Khamis et al. (2013) conducted an observational in severe mitral regurgitation (n=5). MitraClip system was evaluated on acute procedural success defined as clip implant with the reduction of MR to equal or less than grade II. Percutaneous mitral valve repair using the MitraClip system achieved 100% acute procedural success and 0% major adverse events at 30 days in 5 patients with severe mitral regurgitation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: